Gly-Sal 10-2

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gly-Sal 10-2
Generic name: SALICYLIC ACID
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 661cc58b-9360-4b96-b405-afdc2e378397
SPL ID: fa80848d-48a6-42b9-862d-e6094b41cee6
Version: 1
Effective date: 2024-06-13
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:44:25

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Gly-Sal 10-2	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-938-01	openfda.package_ndc
ndc	product	51326-938	openfda.product_ndc
ndc11	package	51326093801	derived:openfda.package_ndc
rxcui		1048903	openfda.rxcui
spl id		fa80848d-48a6-42b9-862d-e6094b41cee6	id
spl set id		661cc58b-9360-4b96-b405-afdc2e378397	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Direct spray away from face, especially eyes, lips and mouth. If irritation develops, discontinue use and consult a doctor. Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Keep out of reach of children. If swallowed, seek professional assistance or contact a Poison Control Center immediately. Flammable; keep tightly closed, away from flame and heat. Sunscreen use is recommended with any Glycolic Acid product and for an additional week thereafter, because some individuals may be more sensitive to sunlight.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.